Skip to main content

Table 1 Baseline demographics and clinical characteristics

From: Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry

Clinical characteristics

N = 2481

Age, years (mean ± SD)

62.76 ± 10.07

Sex (male)

1763 (71.1%)

DM

564 (22.8%)

Insulin treatment for DM

158 (28.0%)

Hypertension

1388 (56.0%)

Chronic renal failure

41(1.7%)

Hypercholesterolemia

1046 (42.2%)

Previous MI

320 (12.9%)

Previous PCI

278 (11.2%)

Previous CABG

17 (0.7%)

Current smoker

56.82 ± 9.25

Clinical presentation

Silent ischemia

54 (2.2%)

Stable angina

170 (6.7%)

Unstable angina

1298 (52.4%)

Non-ST-elevation MI

324 (13.1%)

ST-elevation MI

672 (27.1%)

  1. DM diabetes mellitus, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft